Geode Capital Management’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.46M | Buy |
630,148
+314,407
| +100% | +$1.23M | ﹤0.01% | 3074 |
|
2025
Q1 | $1.2M | Buy |
315,741
+9,990
| +3% | +$37.9K | ﹤0.01% | 3243 |
|
2024
Q4 | $1.66M | Sell |
305,751
-1,207
| -0.4% | -$6.56K | ﹤0.01% | 3198 |
|
2024
Q3 | $1.29M | Buy |
306,958
+70,070
| +30% | +$294K | ﹤0.01% | 3266 |
|
2024
Q2 | $699K | Sell |
236,888
-2,347
| -1% | -$6.93K | ﹤0.01% | 3447 |
|
2024
Q1 | $663K | Buy |
239,235
+20,457
| +9% | +$56.7K | ﹤0.01% | 3515 |
|
2023
Q4 | $621K | Hold |
218,778
| – | – | ﹤0.01% | 3533 |
|
2023
Q3 | $565K | Buy |
218,778
+33,908
| +18% | +$87.5K | ﹤0.01% | 3555 |
|
2023
Q2 | $799K | Hold |
184,870
| – | – | ﹤0.01% | 3441 |
|
2023
Q1 | $283K | Hold |
184,870
| – | – | ﹤0.01% | 3887 |
|
2022
Q4 | $292K | Sell |
184,870
-349
| -0.2% | -$551 | ﹤0.01% | 3901 |
|
2022
Q3 | $229K | Buy |
185,219
+8,197
| +5% | +$10.1K | ﹤0.01% | 4125 |
|
2022
Q2 | $357K | Buy |
177,022
+2,164
| +1% | +$4.36K | ﹤0.01% | 3943 |
|
2022
Q1 | $437K | Buy |
174,858
+7,095
| +4% | +$17.7K | ﹤0.01% | 4003 |
|
2021
Q4 | $625K | Hold |
167,763
| – | – | ﹤0.01% | 3931 |
|
2021
Q3 | $672K | Buy |
167,763
+34,194
| +26% | +$137K | ﹤0.01% | 3886 |
|
2021
Q2 | $594K | Buy |
133,569
+5,101
| +4% | +$22.7K | ﹤0.01% | 3859 |
|
2021
Q1 | $1.18M | Buy |
128,468
+24,769
| +24% | +$227K | ﹤0.01% | 3482 |
|
2020
Q4 | $1.05M | Buy |
103,699
+41,037
| +65% | +$416K | ﹤0.01% | 3355 |
|
2020
Q3 | $265K | Buy |
62,662
+6,250
| +11% | +$26.4K | ﹤0.01% | 3629 |
|
2020
Q2 | $390K | Sell |
56,412
-1,112
| -2% | -$7.69K | ﹤0.01% | 3457 |
|
2020
Q1 | $161K | Buy |
57,524
+39,967
| +228% | +$112K | ﹤0.01% | 3618 |
|
2019
Q4 | $85K | Buy |
17,557
+2,158
| +14% | +$10.4K | ﹤0.01% | 3999 |
|
2019
Q3 | $31K | Buy |
+15,399
| New | +$31K | ﹤0.01% | 4109 |
|